Type 2 & other diabetes

Distinct effects of type 2 diabetes and obesity on cardiopulmonary performance

Diabetes Obes MetabPublished Case-control study

Authors' conclusion

T2D is an independent negative determinant of VO2peak whose effect is additive to other pathophysiological determinants of oxygen uptake, including BMI.

Study context

Population
Patients at high/moderate cardiovascular risk, with or without T2D, free from cardiopulmonary disease, undergoing spirometry and combined echocardiography-cardiopulmonary exercise test
Participants
109 vs 97
Comparison
T2D vs controls
  • T2Dn = 109
  • Controlsn = 97reference
Outcome
VO2peak (oxygen uptake at peak exercise), normalized for fat-free mass in multivariable models
Methodological detailsmultivariable regression analysis
  • Multivariable regression analysis

Main finding

VO2peak

Adjusted reduction in VO2peak

1.0 ml/min/kgFFM

CI −1.7/−0.3

P = 0.0089

By group

As reported in the abstract

Observational data: associations, not effects.

Further findings

BMI · higher with T2D

P = 0.0003

Body mass index (BMI)

Comparable fat-free mass (FFM) between groups

Effect of BMI on VO2peakFFM per unit increase

Adjusted effect of BMI per unit increase, ml/min/kgFFM (p = .06); largely explained by chronotropic incompetence, reduced peripheral oxygen extraction, impaired systolic reserve and ventilatory (in)efficiency
−0.2 (−0.3/0.1)

Subclinical cardiovascular dysfunction in T2D

Concentric left ventricular remodelling, autonomic dysfunction, systolic dysfunction and reduced systolic reserve observed in T2D

Original publication

Distinct effects of type 2 diabetes and obesity on cardiopulmonary performance. Diabetes Obes Metab. Published 12 October 2023. doi:10.1111/dom.15324

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.